@article{ref1,
title="Possible antidotes for suicide risk: What should we tell our patients?",
journal="Psychiatric Annals",
year="2017",
author="Bordelon, S. and Dinwiddie, S.H.",
volume="47",
number="9",
pages="466-470",
abstract="Suicidal behaviors and communications are obvious concerns for psychiatrists. Whereas the infrequency of completed suicide makes it hard to study and the alternative construct of &quot;suicidality&quot; is not uniformly defined across studies, associations can be found between treatments in the psychiatrist's toolbox and possible suicide-protective effects. This review identifies several candidate treatments-psychotherapy, antidepressants, lithium, anticonvulsant agents, electroconvulsive therapy, and clozapine-and weighs their potential suicide-protective effects against their known risks. © SLACK Incorporated.<p /><p>Language: en</p>",
language="en",
issn="0048-5713",
doi="10.3928/00485713-20170803-01",
url="http://dx.doi.org/10.3928/00485713-20170803-01"
}